BLJZY yields 3.41% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, BLJZY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLJZY + JNJ for your $10,000?
Berli Jucker Public Company Limited manufactures, distributes, and services in the areas of packaging, consumer, healthcare and technical, modern retail supply chain, and other group businesses in Thailand. It designs, manufactures, markets, and distributes glass and plastic packaging products, and aluminum cans. The company is involved in the distribution of personal care, household, and stationery and office supplies products, as well as provides logistics management services, such as warehouse, transportation, customs brokerage, and freight forwarding services. In addition, it offers food products comprises snacks, drinks, packaged fruits, and milk and yogurt products. Further, the company imports and distributes medicines, medical supplies, cosmeceuticals, pharmaceuticals, food supplements, and health products; medicines for treatment of various diseases such as nephrology, hematology, cardiology, endocrine system, oncology and tumors, genitourinary system, bones, infections, as well as pediatric medicines and beauty products. Additionally, it also offers medical devices, surgery related products, and emergency medical products and health recovery solutions. The company engages in bakery, food and nutrition, cosmetic ingredients, and industrial chemicals and refrigerants. The company was founded in 1882 and is headquartered in Bangkok, Thailand. Berli Jucker Public Company Limited is a subsidiary of TCC Corporation Company Limited.
Full BLJZY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.